Nicorette Gum Recalled Due to Improper Storage Temperature Conditions
Family Dollar Stores is recalling NICORETTE GUM WHITE ICE MINT 4 MG distributed from April 30 through June 10, 2022. The product was held outside appropriate storage temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II classification with no reported illnesses, injuries, or confirmed incidents. The CGMP deviation related to storage temperature is a manufacturing compliance issue rather than a confirmed safety hazard, consistent with precautionary recalls.
Plain-English summary
NICORETTE GUM WHITE ICE MINT 4 MG in 20-count packages is being recalled. The affected product was distributed to specific Family Dollar Stores nationwide from April 30, 2022 through June 10, 2022, and can be identified by SKU 902014.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The product was held outside appropriate storage temperature conditions.
This recall affects consumers who purchased NICORETTE GUM WHITE ICE MINT 4 MG from Family Dollar Stores between April 30 and June 10, 2022.
Consumers with questions or concerns about this recall should contact Family Dollar Stores, Llc., or visit the FDA's drug recall website for additional information.
The recalled product
- Product
- NICORETTE GUM WHITE ICE MINT 4 MG 20 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- storage-temperature
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 902014
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27